Peter Pytel to Brain Neoplasms
This is a "connection" page, showing publications Peter Pytel has written about Brain Neoplasms.
Connection Strength
3.318
-
Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants. J Neuropathol Exp Neurol. 2021 12 29; 80(12):1134-1136.
Score: 0.573
-
Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations. J Neuropathol Exp Neurol. 2019 03 01; 78(3):257-267.
Score: 0.471
-
Primary Intracranial Myoepithelial Neoplasm: A Potential Mimic of Meningioma. Int J Surg Pathol. 2016 May; 24(3):243-7.
Score: 0.373
-
Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Semin Oncol. 2011 Apr; 38(2):243-53.
Score: 0.272
-
Update on diagnostic practice: tumors of the nervous system. Arch Pathol Lab Med. 2009 Jul; 133(7):1062-77.
Score: 0.241
-
Spectrum of pediatric gliomas: implications for the development of future therapies. Expert Rev Anticancer Ther. 2007 Dec; 7(12 Suppl):S51-60.
Score: 0.216
-
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. Acta Neuropathol. 2023 01; 145(1):71-82.
Score: 0.151
-
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta Neuropathol. 2022 03; 143(3):403-414.
Score: 0.144
-
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas. Sci Transl Med. 2018 07 04; 10(448).
Score: 0.112
-
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 01; 48(1):187-194.
Score: 0.101
-
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer Res. 2016 10 01; 76(19):5671-5682.
Score: 0.099
-
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother. 2015; 15(7):741-52.
Score: 0.091
-
Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma. J Immunol. 2015 Jul 01; 195(1):367-76.
Score: 0.091
-
ßIII-Tubulin Regulates Breast Cancer Metastases to the Brain. Mol Cancer Ther. 2015 May; 14(5):1152-61.
Score: 0.089
-
Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine. 2014 Jan; 10(1):149-57.
Score: 0.080
-
Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas. Cancer Med. 2013 Aug; 2(4):457-67.
Score: 0.079
-
Clinical significance of KISS1 protein expression for brain invasion and metastasis. Cancer. 2012 Apr 15; 118(8):2096-105.
Score: 0.070
-
Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy. Clin Cancer Res. 2007 Oct 15; 13(20):6217-23.
Score: 0.053
-
Intradural spinal Wilm's tumor metastasis: case report. Neurosurgery. 2006 Oct; 59(4):E942-3; discussion E943.
Score: 0.012